ADPKD is common, yet many nephrologists report uncertainty around diagnosis, risk stratification, and timing of intervention. This clinician-focused webinar provides a practical, case-based review of ADPKD care with highlights from the KDIGO 2025 Clinical Guideline.
Through virtual grand rounds, real world cases will illustrate key decision points in diagnosis, monitoring, treatment initiation, and referral. Faculty will review use of tools such as the Mayo Imaging Classification, PROPKD score, genetic testing, and shared decision making around tolvaptan. Participants will gain confidence in identifying rapid progressors and implementing timely, evidence-based interventions.
Presented by:
-
Fouad Chebib, M.D.: Mayo Clinic Florida PKD Center of Excellence Clinic Director
-
Christopher Kwoh, M.D.: The Kidney Institute PKD Center of Excellence Clinic Director
-
Aoun Bahous, M.D., Ph.D., MHPE: Professor of Medicine and Dean of the Lebanese American University School of Medicine
Related Resources
- 2025
- ADPKD
- ADPKD Registry
- Clinical Trials
- Drug Therapy and Treatments
- 2025
- ADPKD
- Webinar
- ADPKD
- Drug Therapy and Treatments
- Management
- Podcast
- Tolvaptan
- Treatment
- 2025
- ADPKD
- Complications
- Living with PKD
- Polycystic Liver Disease
- Webinar
- 2025
- ADPKD
- Caregivers
- Complications
- Education
- Living with PKD
- Newly Diagnosed
- Polycystic Liver Disease
- Symptoms
- The Basics of PKD
- Webinar
- 2025
- ADPKD
- Caregivers
- Complications
- Diagnosis
- Education
- genetic testing
- genetics
- Living with PKD
- Newly Diagnosed
- The Basics of PKD
- Webinar
- 2023
- ADPKD
- PKD
- Progression
- Webinar